source
- Celiac disease is entering a new era of therapeutic innovationFor the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.BioPharma Dive · 1mo ago↗ source
- Planning a successful pivot from lab to clinicFor sterile injectables, key early decisions can have a significant impact on the products’ development.BioPharma Dive · 1mo ago↗ source
- FDA Clears First Over-the-Counter Continuous Glucose Monitor for ChildrenThe U.S. Food and Drug Administration today cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM) for children, Dexcom Inc.’s Stelo Glucose Biosensor System, an in…fda press · 1mo ago↗ source